Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
2(100.0%)
2Total
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT04054453Not ApplicableUnknown

Prevention of Epilepsy by Reducing Neonatal Encephalopathy

Role: collaborator

NCT02471768Completed

The Association Between Central Aortic Blood Pressure Indices and Severity of Coronary Artery Disease

Role: lead

NCT02466139Completed

Early Clinical, Laboratory and Microbiological Predictors of Treatment Outcomes in Infective Endocaridtis

Role: lead

NCT01760629Not ApplicableCompleted

Hypothermia for Encephalopathy in Low Income Countries-Feasibilty

Role: collaborator

All 4 trials loaded